Subcutaneous Versus Combined Subcutaneous and Intramuscular Botulinum Toxin for Androgenetic Alopecia: A Randomized Clinical Trial
Based on our study, we did not find any supportive results for the use of botulinum toxin in the treatment of AGA.
Authors
- Sonia Sofìa Ocampo‐Garza (ORCID: https://orcid.org/0000-0002-0508-5117)
- A A Lima-Galindo
- Jorge Ocampo‐Garza (ORCID: https://orcid.org/0000-0002-1307-3407)
- Antonellá Tosti (ORCID: https://orcid.org/0000-0001-5516-4043)
- Andrea Sarahi Guerra-Garza (ORCID: https://orcid.org/0009-0001-6271-0337)
- Jorge Ocampo‐Candiani
Institutions
- University of Miami (US)
- Universidad Autónoma de Nuevo León (MX)
Publication Details
- Journal
- Actas Dermo-Sifiliográficas
- Published
- 2025-05-26
- DOI
- https://doi.org/10.1016/j.ad.2025.01.012
- Primary Topic
- Botulinum Toxin and Related Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00